PIASCLEDINE is composed of a mixture of soyabean oil unsaponifiables and specific avocado unsaponifiables. This is a unique process that has been patented by Laboratoires Expanscience, a leading pharmaceutical company from France. PIASCLEDINE provides unique triple mode of actions. It prevents the breakdown of cartilage while stimulating the repair of cartilage material and decreases cartilage inflammation. PIASCLEDINE is clinically proven to reduce pain and improve mobility after only two months of treatment and slow osteoarthritis progression. It has no known drug interactions, shows good safety profile and may reduce concomittant consumption of harmful anti-inflammatories.
Avocado oil unsaponifiable 100mg, Soybean oil unsaponifiable 200mg
PIASCLEDINE is indicated for the symptomatic slow-acting treatment of hip and knee osteoarthritis.
Directions For Use
One capsule should be taken once a day after meals with a glass of water. The usual treatment duration is between 3 to 6 months.